Senior insider sale
Chief Executive Officer at LEXEO THERAPEUTICS, INC. — senior position signals high conviction
$314.6K
55K shares
What this filing means
TOWNSEND RICHARD NOLAN plans to sell 55K shares of LEXEO THERAPEUTICS, INC. valued at approximately $314.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/6/2026ACC: 0001968582-26-000351
DirectorOfficer· Chief Executive Officer
Since Feb 2026
55K
Shares to sell
$314.6K
Approx. market value
55K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
CS-3 Incentive Units
Cash
11/20/2020
55KTotal acquired55K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/20/2020 | CS-3 Incentive Units Cash | 55K | — |
| Total | 55K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
55K
Market value
$314.6K
4/6/2026
Total
Units
55K
Value
$314.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/6/2026 | 55K | $314.6K | NASDAQ | Planned |
| Total | 55K | $314.6K | ||